Joint Formulary & PAD

Ursodeoxycholic acid - Gallstones

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Capsules
  • Oral suspension
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
Important
Prescribe generically

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ursodeoxycholic acid
Indication :
Gallstones
Group Name :
Keywords :
Brand Names Include :
Destolit, Urdox, Ursofalk, Ursogal, Cholerso
Important Information :
Transfer of care to primary care may be appropriate after initiation by the specialist.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

Local acute Trusts requested that ursodeoxycholic acid, used in the treatment of gall stones, is changed from Amber* to green. It was agreed that it should remain Amber* as initiation would still need to be carried out by the hospital

Prescribe generically.

Note - the branded product Ursofalk 250mg capsules were considered BLACK at the May 2017 PCN

Other Indications

Below are listed other indications that Ursodeoxycholic acid is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Gallstones.

  • No records returned.